| Positive selection underlies repeated knockout of ORF8 in SARS-CoV-2 evolution C Wagner, KE Kistler, GA Perchetti, N Baker, LA Frisbie, LM Torres, ... Nature Communications 15 (1), 3207, 2024 | 1 | 2024 |
| Local-scale phylodynamics reveal differential community impact of SARS-CoV-2 in a metropolitan US county MI Paredes, AC Perofsky, L Frisbie, LH Moncla, P Roychoudhury, H Xie, ... Plos Pathogens 20 (3), e1012117, 2024 | 5 | 2024 |
| Quantifying how single dose Ad26. COV2. S vaccine efficacy depends on Spike sequence features CA Magaret, L Li, AC deCamp, M Rolland, M Juraska, BD Williamson, ... Nature Communications 15 (1), 2175, 2024 | | 2024 |
| Reanalysis of single-cell RNA sequencing data does not support herpes simplex virus 1 latency in non-neuronal ganglionic cells in mice WJD Ouwendijk, P Roychoudhury, AL Cunningham, KR Jerome, ... Journal of Virology, e01858-23, 2024 | | 2024 |
| Outcomes in Hematopoietic Cell Transplant and Chimeric Antigen Receptor T Cell Therapy Recipients with Pre-Cellular Therapy SARS-CoV-2 Infection I Nimgaonkar, LH Yoke, P Roychoudhury, PW Flaherty, MU Oshima, ... Clinical Infectious Diseases, ciae116, 2024 | | 2024 |
| Clinical outcomes and frequency of persistent infection among immunosuppressed patients treated with bebtelovimab for COVID‐19 infection at an ambulatory cancer center E Sanchez, EM Krantz, L Yoke, M Gallaher, P Bhattacharyya, L So, ... Transplant Infectious Disease 26 (1), e14223, 2024 | | 2024 |
| Variant mutation in SARS-CoV-2 nucleocapsid enhances viral infection via altered genomic encapsidation HC Kubinski, HW Despres, BA Johnson, MM Schmidt, SA Jaffrani, ... bioRxiv, 2024.03. 08.584120, 2024 | | 2024 |
| A cohort-based study of host gene expression: tumor suppressor and innate immune/inflammatory pathways associated with the HIV reservoir size AK Dwivedi, GG Gornalusse, DA Siegel, A Barbehenn, C Thanh, R Hoh, ... PLoS Pathogens 19 (11), e1011114, 2023 | | 2023 |
| Viral Resistance Analyses From the Remdesivir Phase 3 Adaptive COVID-19 Treatment Trial-1 (ACTT-1) C Hedskog, L Rodriguez, P Roychoudhury, ML Huang, KR Jerome, L Hao, ... The Journal of Infectious Diseases 228 (9), 1263-1273, 2023 | 3 | 2023 |
| Sensitivity of rapid antigen tests against SARS-CoV-2 Omicron and Delta variants A Rao, A Westbrook, L Bassit, R Parsons, E Fitts, M Greenleaf, ... Journal of Clinical Microbiology 61 (10), e00138-23, 2023 | 6 | 2023 |
| Risk of COVID-19 after natural infection or vaccination AM Rick, MB Laurens, Y Huang, C Yu, TCS Martin, CA Rodriguez, ... EBioMedicine 96, 2023 | 4 | 2023 |
| Comparing molnupiravir and nirmatrelvir/ritonavir efficacy and the effects on SARS-CoV-2 transmission in animal models RM Cox, CM Lieber, JD Wolf, A Karimi, NAP Lieberman, ZM Sticher, ... Nature Communications 14 (1), 4731, 2023 | 7 | 2023 |
| Clinical and demographic factors associated with COVID-19, severe COVID-19, and SARS-CoV-2 infection in adults: a secondary cross-protocol analysis of 4 randomized clinical trials DA Theodore, AR Branche, L Zhang, DS Graciaa, M Choudhary, ... JAMA network open 6 (7), e2323349-e2323349, 2023 | 8 | 2023 |
| Liver-Humanized NSG-PiZ Mice Support the Study of Chronic Hepatitis B Virus Infection and Antiviral Therapies R Colón-Thillet, D Stone, MA Loprieno, L Klouser, P Roychoudhury, ... Microbiology Spectrum 11 (3), e05176-22, 2023 | 2 | 2023 |
| Respiratory syncytial virus and other respiratory virus infections in residents of homeless shelters–King County, Washington, 2019–2021 DJ McCulloch, JH Rogers, Y Wang, EJ Chow, AC Link, CR Wolf, ... Influenza and Other Respiratory Viruses 17 (6), e13166, 2023 | 6 | 2023 |
| Successful treatment of persistent symptomatic coronavirus disease 19 infection with extended-duration nirmatrelvir-ritonavir among outpatients with hematologic cancer C Liu, LH Yoke, P Bhattacharyya, RD Cassaday, GS Cheng, ZK Escobar, ... Open Forum Infectious Diseases 10 (6), ofad306, 2023 | 3 | 2023 |
| Convergence of immune escape strategies highlights plasticity of SARS-CoV-2 spike X Yu, J Juraszek, L Rutten, MJG Bakkers, S Blokland, JM Melchers, ... PLoS Pathogens 19 (5), e1011308, 2023 | 4 | 2023 |
| Safety, immunogenicity, and efficacy of the NVX-CoV2373 COVID-19 vaccine in adolescents: a randomized clinical trial G Áñez, LM Dunkle, CL Gay, KL Kotloff, JM Adelglass, B Essink, ... JAMA network open 6 (4), e239135-e239135, 2023 | 25 | 2023 |
| Genomic analysis of early monkeypox virus outbreak strains, Washington, USA P Roychoudhury, J Sereewit, H Xie, E Nunley, SM Bakhash, ... Emerging Infectious Diseases 29 (3), 644, 2023 | 3* | 2023 |
| Host variation in type I interferon signaling genes (MX1), C–C chemokine receptor type 5 gene, and major histocompatibility complex class I alleles in treated HIV+ … DA Siegel, C Thanh, E Wan, R Hoh, K Hobbs, T Pan, EA Gibson, ... AIDS 37 (3), 477-488, 2023 | 4 | 2023 |
Alex GreningerUniversity of WashingtonVerified email at uw.edu
